MAM
Akhil Gupta named chief financial officer at NDTV
NEW DELHI: NDTV has appointed Akhil Gupta as chief financial officer, tapping a seasoned finance leader with a track record across media, infrastructure, healthcare and telecommunications, as the network tightens its grip on strategy, governance and capital discipline.
Gupta steps into the role after a stint at Adani Enterprises Limited, where he served as BU finance controller, handling the hard yards of bookkeeping, audits, board processes and working capital, alongside internal financial controls, tax compliance, contract management, TEV studies, credit ratings and term loan facilitation.
Before that, he was head of investor relations, FP&A and internal audit at Zydus Group Cadila Healthcare Limited, where he led investor engagement, disclosures, budgeting, MIS, internal audit and enterprise risk management, bringing structure and rigour to complex, regulated businesses.
His earlier career spans senior finance and FP&A leadership roles at Bharti Infratel Limited and Bharti Airtel Foundation Limited, along with finance responsibilities at PVR Limited, giving him deep exposure to large-scale operations, capital planning and stakeholder management across sectors.
At NDTV, Gupta will oversee financial strategy, governance, compliance and reporting, a brief that puts him at the centre of the broadcaster’s next phase.
For a newsroom where numbers now matter as much as narratives, Gupta’s arrival signals one thing clearly: the balance sheet is back in sharp focus, and there will be no room for sloppy arithmetic.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
